TOKIO MARINE ASSET MANAGEMENT CO LTD
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1504169
Tokyo, M0
Position in XERS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$16,299
New position
Shares Held
2,058
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#199
of 238 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TOKIO MARINE ASSET MANAGEMENT CO LTD holds $7,022,838 across 10 Drug Manufacturers - Specialty & Generic names. XERS ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
56,932 | $4,091,133 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
41,000 | $1,389,080 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
5,568 | $938,430 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
19,900 | $489,739 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
116 | $62,852 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
2,058 | $16,299 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
406 | $14,076 | |
| 8 | LQDA |
Liquidia Corp
|
110 | $8,770 |
All Filings in XERS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,299 | 2,058 | Shares | Defined | 2026-07-30 | |
| No filing history on record for this holder in this stock. | ||||||